|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 1.200 SEK | +1.27% |
|
+91.08% | -37.17% |
| 08-19 | Enorama Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-19 | Calendar Wednesday, August 19 | FW |
Chart: Technical Analysis
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ERMA | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 1.24 | 1.24 | 2.85 |
| Spread/Res. | -3.23% | -3.23% | -57.89% |
| Spread/Supp. | +51.13% | +370.59% | +370.59% |
| Support | 0.794 | 0.255 | 0.255 |
- Stock Market
- Stocks
- ERMA Stock
- Charts Enorama Pharma AB
Select your edition
All financial news and data tailored to specific country editions
